Factors affecting glycemic control among patients with type-2 diabetes mellitus in Rajkot: a cross-sectional study

Pragati H. Hariyani

doi:10.18203/2320-6012.ijrms20261691

Authors

Pragati H. Hariyani Department of Medical-Surgical Nursing, Shri H. N. Shukla Nursing Institute, Rajkot, Gujarat, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20261691

Keywords:

Family Support, Glycemic control, Lifestyle factors, Self-management, Type-2 diabetes mellitus

Abstract

Background: Type-2 Diabetes Mellitus (T2DM) is a rapidly growing public health concern worldwide, particularly in developing countries like India. Despite advancements in treatment modalities, achieving optimal glycemic control remains a major challenge due to multiple influencing factors. The present study aimed to assess factors affecting glycemic control among patients with T2DM attending selected hospitals in Rajkot.

Methods: A descriptive cross-sectional research design was adopted for the study. A total of 70 participants were selected using a purposive sampling technique. Data were collected using a semi-structured interview schedule, the Diabetes Self-Management Questionnaire (DSMQ), and biophysical measurements.

Results: The findings revealed that a majority (87%) of participants had poor glycemic control. Significant factors influencing glycemic control included socio-demographic variables (age, education, and income), clinical factors (duration of diabetes and presence of co-morbidities) and behavioural factors including dietary control, physical activity, and medication adherence. Family support was also found to play a crucial role in diabetes management.

Conclusions: The study concludes that glycemic control is influenced by multiple socio-demographic, clinical, and lifestyle-related variables. Strengthening patient education, promoting self-management practices, and enhancing family involvement are essential to improve glycemic outcomes among T2DM patients.

References

International Diabetes Federation. IDF Diabetes Atlas. 10th ed. Brussels, Belgium: International Diabetes Federation; 2021.

World Health Organization. Global report on diabetes, 2016. Available at: https://www.who.int/publications/i/item/9789241565257. Accessed 01 January 2026.

American Diabetes Association. Standards of medical care in diabetes-2022. Diabetes Care. 2022;45(Suppl 1):S1-S264.

UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control. Lancet. 1998;352:837-53.

Ramachandran A. Glycemic control among urban diabetic population in India. J Assoc Physicians India. 2018;66(3):34-8.

Shrivastava SR, Shrivastava PS, Ramasamy J. Role of self-care in diabetes management. J Diabetes Metab Disord. 2013;12(1):14.

Pradeepa R, Mohan V. Epidemiology of type 2 diabetes in India. Indian J Ophthalmol. 2021;69(11):2932-8.

Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes. Diabetes Care. 2004;27(5):1047-53.

Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. bmj. 2000;321(7258):405-12.

Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New Engl J Medi. 2002;346(6):393-403.

Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, et al. Medical management of hyperglycemia in type 2 diabetes. Diabetes Care. 2009;27(1):4-16.

Ali MK, Bullard KM, Gregg EW. Achievement of goals in U.S. diabetes care. N Engl J Med. 2013;368(78):1613-24.